{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:58:10Z","timestamp":1780876690348,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04339-x","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:50:44Z","timestamp":1777002644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LncRNA LINC01579\/miR-579-3p axis promotes gastric cancer progression via NOTCH1 pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuqing","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixia","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiren","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"issue":"3","key":"4339_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020;18(3):534\u201342.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"4339_CR2","first-page":"195","volume":"106","author":"F Ikeda","year":"2015","unstructured":"Ikeda F, Kiyohasa Y. [The Epidemiology of Gastric Cancer: The Hisayama Study]. Fukuoka Igaku Zasshi. 2015;106(6):195\u2013201.","journal-title":"Fukuoka Igaku Zasshi"},{"issue":"1","key":"4339_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10120-015-0581-1","volume":"20","author":"K Shitara","year":"2017","unstructured":"Shitara K, Chin K, Yoshikawa T, Katai H, Terashima M, Ito S, et al. Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy. Gastric Cancer. 2017;20(1):175\u201381.","journal-title":"Gastric Cancer"},{"issue":"4","key":"4339_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10120-011-0085-6","volume":"14","author":"Y Isobe","year":"2011","unstructured":"Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14(4):301\u201316.","journal-title":"Gastric Cancer"},{"key":"4339_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12876-015-0231-4","volume":"15","author":"P Stahl","year":"2015","unstructured":"Stahl P, Seeschaaf C, Lebok P, Kutup A, Bockhorn M, Izbicki JR, et al. Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer. BMC Gastroenterol. 2015;15:7.","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"4339_CR6","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3748\/wjg.v28.i12.1187","volume":"28","author":"M Ilic","year":"2022","unstructured":"Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187\u2013203.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"4339_CR7","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4339_CR8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/1055-9965.EPI-13-1057","volume":"23","author":"P Karimi","year":"2014","unstructured":"Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700\u201313.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"4339_CR9","first-page":"299","volume":"4","author":"Z Liu","year":"2024","unstructured":"Liu Z, Xu H, You W, Pan K, Li W. Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges. J Natl Cancer Cent. 2024;4(4):299\u2013310.","journal-title":"J Natl Cancer Cent"},{"key":"4339_CR10","doi-asserted-by":"publisher","first-page":"710538","DOI":"10.3389\/fonc.2021.710538","volume":"11","author":"C Lu","year":"2021","unstructured":"Lu C, Wei D, Zhang Y, Wang P, Zhang W. Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects. Front Oncol. 2021;11:710538.","journal-title":"Front Oncol"},{"key":"4339_CR11","doi-asserted-by":"publisher","first-page":"841411","DOI":"10.3389\/fonc.2022.841411","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu Y, Ao X, Wang Y, Li X, Wang J. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance. Front Oncol. 2022;12:841411.","journal-title":"Front Oncol"},{"key":"4339_CR12","doi-asserted-by":"publisher","first-page":"217398","DOI":"10.1016\/j.canlet.2024.217398","volume":"611","author":"J Yuan","year":"2024","unstructured":"Yuan J, Lu J, Zhu J, Chen F, Zeng Z, Yan J, et al. LncRNA FIRRE drives gastric cancer progression via ZFP64-mediated TUBB3 promoter activation. Cancer Lett. 2024;611:217398.","journal-title":"Cancer Lett"},{"issue":"1","key":"4339_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41419-024-07250-z","volume":"16","author":"Y Sun","year":"2025","unstructured":"Sun Y, Zhang H, Shi D-B, Gao P. SP-1-activated LINC01016 overexpression promotes gastric cancer invasion and metastasis through inhibiting EIF4A3-mediated MMP9 mRNA decay. Cell Death Dis. 2025;16(1):54.","journal-title":"Cell Death Dis"},{"key":"4339_CR14","doi-asserted-by":"crossref","unstructured":"Cai Z-R, Zheng Y-Q, Hu Y, Ma M-Y, Wu Y-J, Liu J et al. Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study. Gut. 2025;74(6):884\u201393.","DOI":"10.1136\/gutjnl-2024-333522"},{"key":"4339_CR15","doi-asserted-by":"crossref","unstructured":"Zhang T, Chen Y, Xiang Z. Machine learning-based integration develops a disulfidptosis-related lncRNA signature for improving outcomes in gastric cancer. Artif Cells Nanomed Biotechnol. 2025;53(1):1\u201313.","DOI":"10.1080\/21691401.2024.2440415"},{"issue":"7","key":"4339_CR16","first-page":"6098","volume":"16","author":"B Yang","year":"2024","unstructured":"Yang B, Wang Y, Liu T, Zhang M, Luo T. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma. Aging. 2024;16(7):6098\u2013117.","journal-title":"Aging"},{"issue":"1","key":"4339_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12672-023-00630-5","volume":"14","author":"C-J Qian","year":"2023","unstructured":"Qian C-J, Zhou Y-X, Wu L-K, Wang Y-C, Teng X-S, Yao J. Circ_0000182 promotes cholesterol synthesis and proliferation of stomach adenocarcinoma cells by targeting miR-579-3p\/SQLE axis. Discov Oncol. 2023;14(1):22.","journal-title":"Discov Oncol"},{"issue":"5","key":"4339_CR18","first-page":"230","volume":"24","author":"G Wu","year":"2022","unstructured":"Wu G, Sun P, Qin C. GUSBP11 Inhibited The Progression of Triple Negative Breast Cancer via Targeting The miR-579-3p\/SPNS2 Axis. Cell J. 2022;24(5):230\u20138.","journal-title":"Cell J"},{"issue":"Pt 4","key":"4339_CR19","doi-asserted-by":"publisher","first-page":"136579","DOI":"10.1016\/j.ijbiomac.2024.136579","volume":"281","author":"J Hong","year":"2024","unstructured":"Hong J, Gu R, Cheng W, Lu C, Wang X. LncRNA MACC1-AS1 facilitates the cell growth of small cell lung cancer by sequestering miR-579-3p and mediating NOTCH1-pathway. Int J Biol Macromol. 2024;281(Pt 4):136579.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"4339_CR20","doi-asserted-by":"publisher","first-page":"2501780","DOI":"10.1080\/15384047.2025.2501780","volume":"26","author":"C Zeng","year":"2025","unstructured":"Zeng C, Huang D, Wang L, Liang H, Ma X. Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells. Cancer Biol Ther. 2025;26(1):2501780.","journal-title":"Cancer Biol Ther"},{"issue":"15","key":"4339_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1042\/BCJ20253035","volume":"482","author":"W-S Shim","year":"2025","unstructured":"Shim W-S, Lee S, Azamov B, Lee C, Kang Y, Lee KM, et al. Proteomic analysis reveals inhibition of mevalonate and glycolysis pathways in hepatocytes by 27-hydroxycholesterol. Biochem J. 2025;482(15):1011\u201328.","journal-title":"Biochem J"},{"issue":"16","key":"4339_CR22","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3748\/wjg.v29.i16.2452","volume":"29","author":"W-J Yang","year":"2023","unstructured":"Yang W-J, Zhao H-P, Yu Y, Wang J-H, Guo L, Liu J-Y, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29(16):2452\u201368.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"4339_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005\u201320.","journal-title":"Ann Oncol"},{"key":"4339_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.omto.2021.11.005","volume":"23","author":"Y Liu","year":"2021","unstructured":"Liu Y, Ding W, Yu W, Zhang Y, Ao X, Wang J. Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer. Mol Ther Oncolytics. 2021;23:458\u201376.","journal-title":"Mol Ther Oncolytics"},{"key":"4339_CR25","doi-asserted-by":"crossref","unstructured":"Sun Q, Zhang Y, Yang Q, Chen X, Wang Y, Hou Y et al. Genetic variant in LncRNA-NKILA associated with gastric cancer susceptibility and the binding with miR-6731-5p. Expert Rev Mol Diagn. 2025;25(8):509\u201315.","DOI":"10.1080\/14737159.2025.2499898"},{"issue":"1","key":"4339_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41598-024-84344-w","volume":"15","author":"S-Q Tian","year":"2025","unstructured":"Tian S-Q, Shen J-J, Sun D-P, Chen W-M. lncRNA CHAF1B-2 contributes to the tumorigenesis of gastric cancer by activating the Wnt\/\u03b2-catenin pathway. Sci Rep. 2025;15(1):568.","journal-title":"Sci Rep"},{"issue":"2","key":"4339_CR27","doi-asserted-by":"publisher","first-page":"e70360","DOI":"10.1111\/jcmm.70360","volume":"29","author":"J He","year":"2025","unstructured":"He J, Fu Z, Zou B, Lei X, Lei L, Yang Q, et al. Identification the Cellular Senescence Associated lncRNA LINC01579 in Gastric Cancer. J Cell Mol Med. 2025;29(2):e70360.","journal-title":"J Cell Mol Med"},{"key":"4339_CR28","doi-asserted-by":"publisher","first-page":"965102","DOI":"10.3389\/fonc.2022.965102","volume":"12","author":"P Xu","year":"2022","unstructured":"Xu P, Liu S, Song S, Yao X, Li X, Zhang J, et al. Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma. Front Oncol. 2022;12:965102.","journal-title":"Front Oncol"},{"issue":"8","key":"4339_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/pin.12306","volume":"65","author":"C Wittekind","year":"2015","unstructured":"Wittekind C. The development of the TNM classification of gastric cancer. Pathol Int. 2015;65(8):399\u2013403.","journal-title":"Pathol Int"},{"issue":"1","key":"4339_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41392-023-01576-4","volume":"8","author":"H Ji","year":"2023","unstructured":"Ji H, Hu C, Yang X, Liu Y, Ji G, Ge S, et al. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):367.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"4339_CR31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4240\/wjgs.v12.i12.468","volume":"12","author":"T Lee","year":"2020","unstructured":"Lee T, Teng TZJ, Shelat VG. Carbohydrate antigen 19\u2009\u2013\u20099 - tumor marker: Past, present, and future. World J Gastrointest Surg. 2020;12(12):468\u201390.","journal-title":"World J Gastrointest Surg"},{"issue":"4","key":"4339_CR32","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s10120-023-01384-3","volume":"26","author":"Y Ma","year":"2023","unstructured":"Ma Y, Fu Y, Fan X, Ji Q, Duan X, Wang Y, et al. FAK\/IL-8 axis promotes the proliferation and migration of gastric cancer cells. Gastric Cancer. 2023;26(4):528\u201341.","journal-title":"Gastric Cancer"},{"key":"4339_CR33","doi-asserted-by":"crossref","unstructured":"Schiliro C, Firestein BL. Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation. Cells. 2021;10(5):1056.","DOI":"10.3390\/cells10051056"},{"issue":"1","key":"4339_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41420-022-01161-8","volume":"8","author":"H Wang","year":"2022","unstructured":"Wang H, Liu M, Zeng X, Zheng Y, Wang Y, Zhou Y. Cell death affecting the progression of gastric cancer. Cell Death Discov. 2022;8(1):377.","journal-title":"Cell Death Discov"},{"issue":"Pt 3","key":"4339_CR35","doi-asserted-by":"publisher","first-page":"136455","DOI":"10.1016\/j.ijbiomac.2024.136455","volume":"281","author":"Y Wu","year":"2024","unstructured":"Wu Y, Guo X, Jin L, Huang G, Niu L, Zhao Y. Lnc-LINC00511 promotes gastric cancer progression by regulating MiR-29c-3p\/TRIP13 axis through AKT\/mTOR pathway. Int J Biol Macromol. 2024;281(Pt 3):136455.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"4339_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-024-00568-8","volume":"29","author":"Y Ci","year":"2024","unstructured":"Ci Y, Zhang Y, Zhang X. Methylated lncRNAs suppress apoptosis of gastric cancer stem cells via the lncRNA-miRNA\/protein axis. Cell Mol Biol Lett. 2024;29(1):51.","journal-title":"Cell Mol Biol Lett"},{"issue":"6","key":"4339_CR37","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/hep4.1894","volume":"6","author":"C Quintavalle","year":"2022","unstructured":"Quintavalle C, Meyer-Schaller N, Roessler S, Calabrese D, Marone R, Riedl T, et al. miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed Liver. Hepatol Commun. 2022;6(6):1467\u201381.","journal-title":"Hepatol Commun"},{"issue":"2","key":"4339_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10565-022-09738-w","volume":"39","author":"J Ai","year":"2023","unstructured":"Ai J, Tan G, Li W, Liu H, Li T, Zhang G, et al. Exosomes loaded with circPARD3 promotes EBV-miR-BART4-induced stemness and cisplatin resistance in nasopharyngeal carcinoma side population cells through the miR-579-3p\/SIRT1\/SSRP1 axis. Cell Biol Toxicol. 2023;39(2):537\u201356.","journal-title":"Cell Biol Toxicol"},{"key":"4339_CR39","doi-asserted-by":"publisher","first-page":"156013","DOI":"10.1016\/j.cyto.2022.156013","volume":"159","author":"H Ma","year":"2022","unstructured":"Ma H, Li N, Mo Z. Elevated Notch-1 expression promotes the lymph node metastasis of gastric cancer and the Notch-1-PTEN-ERK1\/2 signalling axis promotes the progression of gastric cancer. Cytokine. 2022;159:156013.","journal-title":"Cytokine"},{"key":"4339_CR40","doi-asserted-by":"publisher","first-page":"9939","DOI":"10.12659\/MSM.918703","volume":"25","author":"B Huang","year":"2019","unstructured":"Huang B, Jin G, Qu C, Ma H, Ding C, Zhang Y, et al. Elevated Expression of NOTCH1 Associates with Lymph Node Metastasis of Gastric Cancer and Knock-Down of NOTCH1 Attenuates Tumor Cell Progression. Med Sci Monit. 2019;25:9939\u201348.","journal-title":"Med Sci Monit"},{"issue":"16","key":"4339_CR41","doi-asserted-by":"publisher","first-page":"11893","DOI":"10.18632\/aging.206061","volume":"16","author":"L Zhou","year":"2024","unstructured":"Zhou L, Yang Y, Ye Y, Qiao Q, Mi Y, Liu H, et al. Notch1 signaling pathway promotes growth and metastasis of gastric cancer via modulating CDH5. Aging. 2024;16(16):11893\u2013903.","journal-title":"Aging"},{"issue":"12","key":"4339_CR42","doi-asserted-by":"publisher","first-page":"16471","DOI":"10.18632\/aging.203167","volume":"13","author":"J Xu","year":"2021","unstructured":"Xu J, Xu W, Yang X, Liu Z, Sun Q. LncRNA HCG11\/miR-579-3p\/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch\/Hes1 signaling pathway. Aging. 2021;13(12):16471\u201384.","journal-title":"Aging"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04339-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04339-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04339-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T23:04:45Z","timestamp":1780873485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04339-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4339"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04339-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by The Ethics Committee of Jiangsu Second Traditional Chinese Medicine Hospital and followed the principles outlined in the Declaration of Helsinki. In addition, informed consent has been obtained from the participants involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}